PF-Atlas › Clinical Trials › NCT06482190
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
RSN0402 Part 1 · Phase 1
Registry ID
NCT06482190
Phase
Phase 1
Status
Unknown
Drug / intervention
RSN0402 Part 1
Sponsor
Shenzhen Resproly Biopharmaceutical Co., Ltd
Start
2024-07-11
About this trial
RSN0402 Part 1 is evaluated in NCT06482190, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Shenzhen Resproly Biopharmaceutical Co., Ltd. Current status: Unknown.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06482190 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.